Place · Level 3

Essential vs Non-essential · the line is drawn on rates

必需 = 造得不够快, 不是造不出来 · 两个速度都会动 · 猫的两个酶相乘 · PKU 一个酶翻两栏 · 早产儿那把还没上线的剪刀

Story path

1Not a property of the moleculeNot a property of the molecule
2The two ratesThe two rates
3The cat · same molecule, other columnThe cat · same molecule, other column
4PKU · one enzyme, both columns flipPKU · one enzyme, both columns flip
5The enzyme not online yetThe enzyme not online yet
6What to ask next timeWhat to ask next time

Chapter 1

Not a property of the molecule

Whether your body can make something, and whether you need to eat it, are two different questions.

Nutrition textbooks sort the 20 amino acids into two columns: 9 essential, 11 non-essential. The table looks like the periodic table, as if essentiality were a property the molecule carries — stamped on it like atomic weight, fixed forever.

It isn't. That line is drawn on rates.

The US National Academy of Medicine's Dietary Reference Intakes report gives a plain definition: an amino acid counts as conditionally indispensable when it requires a dietary source because endogenous synthesis cannot meet metabolic need (IOM 2005).

Not one word in that sentence describes a molecule. Every word describes a rate: the rate of making, the rate of using, and which one falls behind.

So the real classification has three columns, not two. In the IOM's table, six amino acids stand in the middle: arginine, cysteine, glutamine, glycine, proline, tyrosine. Normally the body makes enough of them; in certain states it doesn't, and then you have to eat them.

The crucial part is that both rates move. The making rate can fall: an enzyme is naturally sluggish, hasn't developed yet, or has been broken by a mutation. The using rate can rise: the body is growing, repairing a wound, inflamed. When the two rates cross, the same molecule slides out of the non-essential column and into the essential one.

Essentiality is not a property of the molecule. It is a property of the body's state. The three examples that follow are all about this one thing.

Three columns · who is built from what

Besides listing the six conditionally indispensable amino acids, the IOM's table lists what each one is built from — and that column is the real point:

Tyrosine ← phenylalanineCysteine ← methionine, serineArginine ← glutamine / glutamate, aspartateGlycine ← serine, cholineProline ← glutamateGlutamine ← glutamate, ammonia
Every arrow is an enzyme pathway. Whether an arrow can keep up with demand depends on two things: whether enough precursor is queued at the front, and how fast the enzymes in between run. Break either end and this non-essential amino acid becomes essential.

One detail slips past most readers: tyrosine's upstream is phenylalanine, and phenylalanine is itself an essential amino acid. So tyrosine's non-essential status is borrowed — it rests on two premises: that you ate enough phenylalanine, and that the enzyme converting phenylalanine to tyrosine still works. Scene four shows what happens when both premises collapse at once.

Something even more telling hides in that table's footnote: histidine sits in the essential column, yet the report itself concedes histidine doesn't meet the criterion the report uses to judge essentiality — removing it from the diet doesn't promptly drive negative nitrogen balance the way the other eight do (IOM 2005).

Which is to say: the table doesn't even enforce its own criterion. Reeds 2000 pushes this further in review: from a functional standpoint, all amino acids are essential; the textbook dichotomy is a historical operational convention measured with nitrogen-balance experiments, not the body's own taxonomy (Reeds 2000).

Open this on the map

Chapter 2

The two rates

Unpack the previous scene's definition and only two quantities are inside it: how much of this molecule your body can build per hour, and how much it spends per hour.

The making side is an enzyme assembly line.

Molecules don't appear from nowhere. A precursor enters, queues through several enzymes, each nudging its structure a little, until a finished product comes out. How much this line ships per hour is set by two things: how much precursor is queued at the front, and how many molecules per second the slowest enzyme in the queue can handle.

Here's an easily missed piece of arithmetic. If two enzymes on one line are both slow, their effects multiply rather than add. The first enzyme passes only a tenth, the second passes only a tenth of that, and just one percent completes the trip. The cat in scene three dies on exactly this multiplication.

The using side isn't one destination — it's several draining at once.

The finished molecule gets pulled in several directions at once inside the cell: built into a protein under construction, converted into something else, torn down and burned for energy, or hooked onto another molecule and excreted. These exits run in parallel, drawing on the same pool. Open any one exit wider and the others receive less.

So essentiality is a comparison between two rates, not a lookup in a table.

And both sides move:

The making side falls: an enzyme is naturally sluggish (a species matter), hasn't developed yet (an age matter), has been broken by a mutation (a disease matter), or the precursor itself can't keep up (a diet matter).The using side rises: the body is growing, a wound is repairing, inflammation is running. The IOM's example is glutamine — under severe catabolic stress, tissue capacity to produce glutamine can't match the increased need, so this normally non-essential amino acid requires a dietary source (IOM 2005).
Glycine is where this logic has been worked out most carefully in humans: Meléndez-Hevia 2009 added up an adult's daily glycine spending item by item, compared it against the output of the serine synthesis pathway, and found the output clearly falls short (Meléndez-Hevia 2009). How that ledger is calculated is covered end to end on the glycine island; it isn't repeated here. What this story wants isn't that number — it's that move: putting the two rates side by side.

Why the two-column table still works

If essentiality flips this easily, why has the two-column table survived a century?

Because for most people, most of the time, those 11 non-essential amino acids really are synthesized fast enough. The table isn't wrong — it records the answer in the default state. What's wrong is reading a snapshot as a law.

The IOM spells out this limit on the same page: it concedes that quantitative requirements for conditionally indispensable amino acids have not been determined, and presumably vary greatly according to the specific condition (IOM 2005). In other words, the official guideline knows the line moves but offers no number for where it moves to.

That sentence is worth holding onto, because it's the foundation for every judgment later in this story. When a national guideline lists six conditionally indispensable amino acids and then immediately says it doesn't know their requirements, any product on a shelf handing you a precise conditionally-essential dose is more confident than the guideline.

One note on scope. This story is about why the line moves — not what to do once it has. The latter belongs to clinical nutrition.

Open this on the map

Chapter 3

The cat · same molecule, other column

Taurine isn't essential for you. It is for your cat. The difference isn't the molecule — it's the activity of two enzymes.

Taurine is a small molecule all mammals use. You can build it from cysteine, however much you manage, and nothing goes wrong if you never eat any. On that two-column table it doesn't even have a seat.

In a cat, the two rates look like this.

The making side: two slow enzymes, and they multiply.

Cats actually have the whole taurine pathway; no parts are missing. But two enzymes on that line have low activity: cysteine dioxygenase (which oxidizes cysteine to cysteine sulfinic acid) and cysteine sulfinic acid decarboxylase (which turns that into hypotaurine). In Morris's own words, when the activities of two enzymes in a pathway are greatly reduced there is a multiplicative effect, and the traffic along the pathway becomes insignificant (Morris 2002).

A cat's cysteine isn't idle — it simply goes elsewhere: most of it is metabolized to pyruvate and burned as an energy substrate, whereas taurine cannot be oxidized by cats at all (Morris 2002). The raw material is there; it just doesn't turn toward taurine.

The using side: cats have a permanent exit you don't have.

Bile acids need an amino acid attached to do their job. You can use either — glycine or taurine, whichever. Cats can't: their conjugating enzyme has very low affinity for glycine, so cats must use taurine to conjugate bile acids (Morris 2002). Every time a cat digests fat, it pours taurine into its gut.

Squeezed from both sides. Morris is explicit: what actually depletes the cat's body taurine pool is the combination of low synthetic activity and that extremely low glycine affinity (Morris 2002). Neither alone is enough; it takes both rates together.

The cost is concrete. Taurine-deficient cats develop feline central retinal degeneration (the central patch of retina responsible for sharp vision degenerates), and dilated cardiomyopathy — heart muscle thins, chambers balloon, and the pump fails. Pion 1987 reported in Science that cats fed commercial foods showed low plasma taurine with echocardiographic myocardial failure; after oral taurine supplementation, left ventricular function returned to normal (Pion 1987). That is why cat food today must have taurine added.

Note what this scene is really about. Not one atom of the taurine molecule changed. What changed is the body reading it.

morris-2002-cat-nutrient-idiosyncrasy

Even the cat's requirement isn't fixed

The taurine number on a cat food label looks like a species constant. It isn't.

Some of the taurine poured into the gut via bile gets reabsorbed; that recycling loop is the enterohepatic circulation. Morris's group found how much comes back depends on what the cat eats: diets with a high percentage of indigestible protein increase cholecystokinin secretion and favour a gut flora that degrades taurine. The taurine is eaten by bacteria before it can be reabsorbed, recovery drops, and the amount the cat must eat each day goes up (Morris 2002).

So Morris concludes the dietary requirement for taurine is not fixed — it depends on the dietary ingredients and how they were processed (Morris 2002). This isn't a paper inference: canned diets need about twice as much taurine as expanded diets (Morris 2002). Same cat, different food, different requirement.

This layer cuts deeper than the last. The previous layer said essentiality varies by species. This one says that even within one species, even in one cat, it varies with what's in the bowl today.

One last question: why did cats evolve this way? Morris's account is that wild cats ate whole small mammals and birds, organs included — animal tissue is itself taurine-rich, enough to meet the need without synthesis. Under that diet there's no payoff to maintaining an expensive synthetic pathway, so those two enzyme activities decayed (Morris 2002).

Put differently: the diet moved first, the enzyme retreated after. But Morris adds an important limit in his own abstract: this retrospective viewpoint allows only recognition of association rather than cause and effect (Morris 2002). So the evolutionary account is a reasonable story, not a proven mechanism. It's cited here because it asks the right question: instead of asking whether this molecule is important, ask what conditions shaped this body into its current form.

morris-2002-cat-nutrient-idiosyncrasy

Open this on the map

Chapter 4

PKU · one enzyme, both columns flip

The last scene changed species. This one doesn't need to — in the same person, one broken enzyme flips two directions at once.

First, where the enzyme is and what it does. Your liver cells carry an enzyme called phenylalanine hydroxylase (PAH). Its job is plain: grab a phenylalanine molecule and press an oxygen atom onto its benzene ring, and phenylalanine becomes tyrosine (IOM 2005). The step needs a helper molecule alongside it, tetrahydrobiopterin (BH4). In roughly a fifth of patients, giving BH4 can push residual PAH activity up somewhat (Blau 2010).

That single reaction is the answer to two things at once:

It is phenylalanine's main exit. Whatever phenylalanine you eat and don't use mostly leaves through here.It is tyrosine's only entrance. Tyrosine has just this one endogenous route, and the route is one-way: phenylalanine can become tyrosine, but tyrosine cannot go back (IOM 2005).
Phenylketonuria (PKU) is a genetic disorder that strips PAH of activity. When that one enzyme collapses, both things break at once.

Direction one: an essential amino acid becomes something to restrict.

Phenylalanine is a genuinely essential amino acid — the body cannot build that benzene ring, so it must be eaten. But once PAH is broken, the main exit shuts and ingested phenylalanine piles up in blood. Persistently elevated phenylalanine causes irreversible brain damage during the critical window of brain development — unless dietary phenylalanine is restricted within one month of birth and kept restricted (IOM 2005). So: essential, but must be limited. Those two words don't normally land on the same amino acid.

Direction two: a non-essential amino acid becomes essential.

Tyrosine is normally non-essential for exactly one reason — you can build it from phenylalanine using PAH (IOM 2005). Break PAH and that reason evaporates. van Spronsen 2001 puts it bluntly: people with PKU cannot synthesize tyrosine from phenylalanine because of a severe deficiency of the hepatic enzyme, and therefore in these persons tyrosine is an essential amino acid (van Spronsen 2001).

Same enzyme. Same person. The essential one became the one to restrict; the non-essential one became essential. No molecule changed its structure.

This is why the first scene's claim had to be stated so absolutely: essentiality isn't written on the molecule, it's written on the pathway — and pathways break.

PKU is found by newborn heel-prick screening and managed lifelong by metabolic physicians and dietitians. This story teaches mechanism, not protocol; every concrete decision about a PKU diet must be made by that specialist team.

Becoming essential is not becoming useful

This scene has a pit that's easy to slide past, and it deserves its own page.

Tyrosine becomes an essential amino acid in PKU — that's a mechanistic fact. But essential only means it must come from food. It does not mean more is better, and it certainly does not mean adding extra free tyrosine helps. There is no logical bridge between those sentences.

Here's the actual evidence. The special amino acid formula people with PKU consume already contains added tyrosine — the problem is that even so, blood tyrosine often still runs low. van Spronsen 2001 reviewed this and judged the current practice of dosing tyrosine across the day far from optimal, because it fails to prevent low blood tyrosine; their recommendation was instead to limit tyrosine in protein substitutes to around 6% by weight and to avoid extra free tyrosine without biochemical evidence of deficiency (van Spronsen 2001).

So does supplementing tyrosine beyond the formula help? A Cochrane systematic review searched: it found only 3 randomized controlled trials, 56 people total. Blood tyrosine did go up — but no other outcome measure differed. The authors concluded that from the available evidence, no recommendation can be made about whether tyrosine supplementation should enter routine clinical practice (Remmington 2021).

Put those two together and you get the judgment this story is trying to teach:

Mechanism says tyrosine is essential in PKU. That sentence is correct, and it was derived from an enzyme.But mechanism cannot answer so how much should I take. That's a separate question, answered by separate trials, and those trials currently answer: we don't know.
When a molecule moves from non-essential to essential, the only thing that changed is that it must now come from food. It tells you nothing about dose, nothing about form, nothing about timing. This is supplement marketing's favorite substitution: show you a beautiful mechanism, then let you assume the mechanism has approved the dose.

remmington-2021-cochrane-tyrosine-pku

Open this on the map

Chapter 5

The enzyme not online yet

The enzymes in the last two scenes were naturally slow (the cat) and broken by mutation (PKU). There's a third kind: the enzyme is fine, it just hasn't clocked in yet.

Cysteine isn't normally essential, because you can build it. Methionine brings sulfur in, travels a route called the transsulfuration pathway, the sulfur is handed onto a serine backbone, and cysteine is finally cut loose. The last step of that route is done by an enzyme called cystathionase — it snips the intermediate cystathionine so cysteine drops out.

In 1970, Sturman and colleagues reported in Science that in the livers of human fetuses and premature infants they could not measure any activity of this enzyme, and that the placenta doesn't perform this step on the fetus's behalf either. From this they drew the natural inference — for the immature human, cysteine may be an essential amino acid (Sturman 1970).

The inference sounds airtight: no scissors, no cutting. The IOM likewise lists prematurity, where the rate at which cysteine can be produced from methionine is inadequate, as a canonical example of conditional indispensability (IOM 2005).

Then somebody actually measured.

Riedijk 2007 used isotope tracer methods on low-birth-weight infants born at 32 to 34 weeks who were 4 weeks old at the time of study. They fed formulas with different cysteine concentrations and watched whether the body's response differed. It didn't. The authors' conclusion is carefully worded — in these 4-week-old low-birth-weight preterm infants born at 32 to 34 weeks, there is no evidence for limited endogenous cysteine synthesis (Riedijk 2007).

This doesn't mean the 1970 paper was wrong. The two papers measured fundamentally different things, in different states:

Sturman measured whether the enzyme is present, in fetuses and just-born premature infants.Riedijk measured whether the rate is sufficient, in 32-to-34-week infants already 4 weeks past birth and receiving ample methionine.
Here's the real lesson: even whether the enzyme is present isn't the answer to this question.

A missing enzyme only tells you the making side is slow. It doesn't tell you how slow, and it says nothing about how fast the using side is running. Only holding the two rates up against each other produces an answer — and both rates move with the weeks since birth and with how much precursor is being fed alongside.

So the phrase preterm infant is far too coarse. How preterm? How many weeks old now? Is precursor keeping up? These aren't details. These are the question itself.

riedijk-2007-preterm-cysteine

What moves the two rates

Let's gather what the previous scenes pulled apart. There really aren't many things that move those two rates — four categories.

The making side gets dragged down by:

Species: enzyme activity simply differs by birth, like the cat's two enzymes.Development: the enzyme hasn't started being expressed, or only just has, like the fetus's cystathionase. This category has a distinctive feature — it carries a clock, and the answer changes in a few weeks.Damage: a mutation strips the enzyme of activity, like PAH in PKU. This category has no clock; it's lifelong.Missing material: the enzyme is fine, but the precursor upstream can't keep up. Tyrosine runs on this — its synthesis depends on an adequate dietary supply of its indispensable precursor, phenylalanine (IOM 2005).
The using side gets pushed up by:

Growing: while the body is growing, every structural material is being spent at a high rate. The IOM notes that in premature infants fed mainly human milk, glycine supply may be a primary nutritional limitation to growth — so this normally non-essential amino acid may count as conditionally indispensable for them (IOM 2005).Repairing or inflamed: under catabolic stress, tissue capacity to produce glutamine can't match the increased need (IOM 2005).
Stop here, though. How to supply amino acids in critical illness, trauma, or sepsis is a specialist clinical-nutrition question, managed by dedicated teams and guidelines, and this story offers no protocol on it. Those states serve exactly one purpose here: proving the using side genuinely moves, and can move far enough to flip the classification.

One last note on the IOM's own honesty. Having listed these six amino acids as conditionally indispensable, it concedes in the same breath that their quantitative requirements have not been determined and presumably vary greatly according to the specific condition (IOM 2005). The guideline knows the line moves; it offers no number for where. The next scene is about what that sentence means in practice.

Open this on the map

Chapter 6

What to ask next time

One sentence is enough: when you see the word essential, first ask — for whom, and in what state?

This story doesn't hand you a new table. It hands you two questions. They cut in opposite directions, and marketing works both ends.

End one: someone tells you this is a non-essential amino acid, the body makes it, don't worry about it.

That sentence dropped its subject and its state. Ask back: for whom? In what state? What's the making rate, what's the using rate, and which one falls behind?

Tyrosine genuinely needs no attention from the vast majority of people — but for someone with PKU the same sentence is wrong, and dangerously so. Non-essential was never a promise. It's an observation that holds in the default state.

End two: someone tells you this is a conditionally essential amino acid, so you should supplement it.

That sentence skipped the entire derivation. Conditionally essential means, in full: under certain conditions, the synthesis rate falls behind the usage rate. So ask back: am I in that condition? Is my synthesis rate actually falling behind? On what basis do you say so?

Supplement marketing loves the phrase conditionally essential precisely because it sounds both technical and alarming. It converts a conditional judgment into a judgment about you. And the condition usually means severe illness, trauma, prematurity, or a genetic defect. If you aren't in those conditions, the phrase doesn't apply to you.

And there's a harder boundary still.

Even if you are in that condition, the verdict essential only establishes that it must come from food. It doesn't establish how much to take. The IOM concedes as much: quantitative requirements for conditionally indispensable amino acids have not been determined and presumably vary greatly with the specific condition (IOM 2005). Tyrosine in PKU is the living lesson — one hundred percent essential mechanistically, yet on whether extra supplementation helps, Cochrane's verdict after 3 trials and 56 people is: we don't know (Remmington 2021).

So anyone who can hand you a precise conditionally-essential dose is more confident than the US National Academy of Medicine. That by itself is a signal.

This story is education, not a substitute for a doctor. If you genuinely are in a state that moves these two rates — an inherited metabolic disease, preterm infant feeding, nutritional support after serious illness or trauma — all of these have specialist teams and dedicated guidelines. Hand it to them. Don't try to solve it with supplements.

remmington-2021-cochrane-tyrosine-pku

Red flags · don't handle these alone

None of the three states in this story can be handled by tweaking your diet or buying a supplement. Each has its own medical path:

Newborn metabolic screening: PKU is caught by a heel-prick blood test in the first days of life. Found early and controlled strictly by diet, the irreversible brain damage is avoided; found late, the damage already done cannot be taken back (IOM 2005). This is one of the reasons newborn screening exists. Don't skip it.Preterm infant feeding: what to feed and how much is decided by the neonatal team based on weight and gestational age. The two studies cited in this story are precisely the demonstration that even professionals need tracer experiments to settle this — parents certainly shouldn't reason it out themselves.Nutritional support after serious illness or trauma: this is clinical nutrition's territory, with dedicated teams.
Also, if any of these show up, see a doctor rather than researching which amino acid to take:

Unexplained weight lossWounds that won't healRecurrent infectionsUnexplained persistent fatigue
These symptoms genuinely can relate to protein and amino acid supply — but they're more likely signals of something else. The danger in pushing symptoms down with a supplement is that it covers up the real cause.

To keep going: the protein island covers the division of labor among the 20 amino acids and how much to eat per meal; the glycine island works the making-it-too-slowly problem end to end on one concrete molecule, and is the most complete human case of the logic in this story.

Open this on the map